DCOY (Decoy Therapeutics) FFO


DCOY Decoy Therapeutics Inc DCOY
23 GF Score
Price $6.02
! 3 Warning Signs
View Full Analysis

What is Decoy Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

DCOY
23GF Score
Decoy Therapeutics Inc DCOY
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Decoy Therapeutics Business Description

Address 2450 Holcombe Boulevard, Suite X, Houston, TX, USA, 77021
Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.
23GF Score

Get the complete analysis for DCOY

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.02
Price